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Strengths and limitations of this study
 ► To our knowledge, this study is the first to use mixed 
methods integrative analyses to explore the relation-
ship between quality of intervention development 
work and treatment success.
 ► Using the National Institute of Health Research 
Health Technology Assessment Journal mono-
graphs, published protocols and other supporting 
publications for each study together provided a de-
tailed and rich source of data beyond what would be 
found in a single traditional journal publication.
 ► The study reviewed randomised controlled trials of 
physical rehabilitation from a single UK funder as 
an exemplar and therefore findings may not be rep-
resentative of other complex interventions or other 
funding bodies.
AbStrACt
Objectives Physical rehabilitation is a complex process, 
and trials of rehabilitation interventions are increasing in 
number but often report null results. This study aimed to 
establish treatment success rates in physical rehabilitation 
trials funded by the National Institute of Health Research 
Health Technology Assessment (NIHR HTA) programme and 
examine any relationship between treatment success and 
the quality of intervention development work undertaken.
Design This is a mixed methods study.
Setting This study was conducted in the UK.
Methods The NIHR HTA portfolio was searched for all 
completed definitive randomised controlled trials of 
physical rehabilitation interventions from inception to 
July 2016. Treatment success was categorised according 
to criteria developed by Djulbegovic and colleagues. 
Detailed textual data regarding any intervention 
development work were extracted from trial reports and 
supporting publications and informed the development 
of quality ratings. Mixed methods integrative analysis 
was undertaken to explore the relationship between 
quantitative and qualitative data using joint displays.
results Fifteen trials were included in the review. 
Five reported a definitive finding, four of which were 
in favour of the ‘new’ intervention. Eight trials reported 
a true negative (no difference) outcome. Integrative 
analysis indicated those with lower quality intervention 
development work were less likely to report treatment 
success.
Conclusions Despite much effort and funding, most 
physical rehabilitation trials report equivocal findings. 
Greater focus on high quality intervention development 
may reduce the likelihood of a null result in the definitive 
trial, alongside high quality trial methods and conduct.
bACkgrOunD
Rehabilitation is ‘a set of interventions designed 
to optimise function and reduce disability in indi-
viduals with health conditions in interaction with 
their environment’1 and is an essential aspect 
of healthcare provision. By its very nature, 
rehabilitation in clinical practice is an indi-
vidually focused, complex activity, involving 
interventions that are multifaceted and often 
implicit in nature,2 and as such, historically, 
this has been viewed as a barrier to under-
taking research.3 This said, there is a growing 
body of randomised controlled trials (RCTs) 
of rehabilitation, suggesting that these chal-
lenges can be overcome.4 This may, in part, be 
supported by the publication of the Medical 
Research Council (MRC) Framework for 
developing and evaluating complex interven-
tions.5 6
The MRC framework was developed to 
optimise the likelihood that new interven-
tions are not rejected as being ineffective 
when inadequate effort has been made in 
the development of the intervention.7 Like-
wise, Chalmers and Glasziou8 highlighted the 
importance of avoiding research waste and 
recommended that sufficient effort is made 
to ensure the relevant research questions are 
identified and addressed using high quality 
research methods. However, there appears to 
have been no formal evaluation of the impact 
of using the development component of the 
framework on trial outcomes and whether we 
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are observing evidence of effective interventions being 
developed.
Previous UK9 and US10 reviews synthesised successful 
and non-successful treatment outcomes from trials of 
new interventions in order to assess the equipoise prin-
ciple and to understand what return has been achieved 
on the investment made by those taking part in the trials, 
researchers and funders. Dent and Raftery9 reported 
24% (20/85) primary outcome comparisons as having 
a positive result, of which 19% (16/85) were in favour 
of the new intervention, with 22% (19/85) compari-
sons reporting a true negative outcome. However, these 
authors did not focus on rehabilitation interventions, 
nor did they seek to understand factors that may impact 
on treatment success, such as the quality or intensity of 
intervention development pretrial procedures. Informal 
discussions with colleagues in the UK and internationally 
noted that an increasing number of publicly funded, large 
RCTs evaluating physical rehabilitation interventions 
had reported null findings. Similar concerns have been 
reported in studies of public health interventions.11 12 
Our study, therefore, sought to assess this observation and 
also explore whether intervention development activities 
contributed to treatment success using the National Insti-
tute of Health Research Health Technology Assessment 
programme (NIHR HTA) as an exemplar.
We aimed to use data from the NIHR HTA to
a. Establish the treatment outcomes of funded RCTs of 
physical rehabilitation.
b. Establish how many new interventions were found to 
be effective.
c. Examine what work had been done in terms of devel-
oping the new intervention.
d. Examine the relationship between (a) and (c).
We adopted a mixed methods approach to address 
the study aims. Although evidence of using integrative 
mixed methods approaches in synthesising evidence on 
complex interventions is limited, mixing together quali-
tative and quantitative data can generate understanding 
that has the potential to be greater than the sum of the 
individual parts.13
MethODS
Design
We undertook a review of NIHR HTA funded RCTs of 
physical rehabilitation interventions using narrative 
synthesis of outcomes and mixed methods analysis of the 
relationship between intervention development and cate-
gorical treatment outcomes using joint displays.
Patient and public involvement
Patients and the public were not involved in this study.
Data sources and inclusion criteria
We included superiority RCTs of physical rehabilitation 
funded by the NIHR HTA programme. The interven-
tions could be delivered by a single profession or be 
multiprofessional. The NIHR HTA programme is the 
leading public funding source for RCTs in the UK and 
trials of rehabilitation are increasingly part of the port-
folio. We only included completed RCTs whose main 
trial findings were reported in an HTA monograph or 
peer-reviewed publication in order to establish treatment 
success. We excluded pilot and feasibility RCTs as they do 
not aim to assess the efficacy or effectiveness of interven-
tions14; studies where the interventions were primarily 
psychological or cognitive as the focus of the study was 
physical rehabilitation; where the primary outcome find-
ings were not reported with a 95% CI as these data were 
required to assess treatment success.
Search and screening
We searched the HTA Project Portfolio (since superseded 
by the NIHR Journals Library https://www. journalsli-
brary. nihr. ac. uk/#/) from inception to July 2016 using 
the following keywords: physiotherap*OR occupational 
therap* OR speech and language therap* OR rehabili-
tation. We removed duplicate, and then titles and scien-
tific abstracts were reviewed for potential inclusion by one 
person and checked by a second. Subsequently full text 
reports were screened for inclusion by one person and 
checked by a second. Any disagreements were discussed 
and agreed with a third person.
Data extraction
All data were extracted by one person and checked by a 
second. Discrepancies were discussed and resolved with a 
third person.
Quantitative trial data
Data extracted from each trial publication included 
trial design, target population, health categories (using 
the Health Research Classification System), primary 
outcome(s) and time point, minimal important clinical 
difference or percentage change that the trial aimed to 
detect, planned and achieved sample size, and primary 
outcome results with 95% CI. We also recorded the profes-
sional background of the chief investigator and amount 
of funding awarded.
Qualitative intervention development data
Using the revised version of Criteria for Reporting the 
Development and Evaluation of Complex Interventions 
(CReDECI 2)15 and the Template for Intervention Descrip-
tion and Replication checklist (TIDieR)16 as frameworks, 
we extracted all available documentary (qualitative) data 
from the body of the text regarding intervention develop-
ment, including descriptions of underlying theory, inter-
vention components and reasons for selection, intended 
interactions between components, contextual consid-
erations, piloting of intervention and impact of defin-
itive intervention to be evaluated, control components, 
planned intervention delivery and materials. Where 
additional supporting publications were cited, such as a 
protocol or intervention development studies, we used 
these as additional sources of documentary data.
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Figure 1 Study selection. HTA, Health Technology 
Assessment; RCT, randomised controlled trial.
Data analysis
We used summary statistics to describe the characteristics 
of the included studies. We categorised primary outcome 
findings into one of six treatment outcome categories as 
described by Djulbegovic and colleagues,10 these being (1) 
statistically significant in favour of the new treatment, (2) 
statistically significant in favour of the control treatment, 
(3) true negative, (4) truly inconclusive, (5) inconclusive 
in favour of new treatment or (6) inconclusive in favour 
of the control treatment. This was achieved by comparing 
the 95% CI for the difference in primary outcome to the 
difference specified in the sample size calculation.9 If the 
95% CI excluded a meaningful difference in either direc-
tion, implying the treatments have similar effects, the 
results were categorised as true negative. If the 95% CI 
included a meaningful difference in either direction (ie, 
trial failed to answer the primary question), the results 
were categorised as being truly inconclusive.
Where a single primary outcome and primary time 
point were not explicitly identified, we used the following 
hierarchy to determine which primary outcome would be 
used in the analysis:
 ► Explicitly defined primary outcome.
 ► Outcome used in power calculation.
 ► Main outcome stated in trial objectives.
 ► First outcome reported in sample size calculation.
If a primary time point was not reported, we used the 
first follow-up time point as this is when we would expect 
the intervention to have had the greatest effect.
Our preliminary analysis of the qualitative documen-
tary data involved the reading and re-reading of source 
documents and the extracted descriptions to consolidate 
our understanding of the development work undertaken 
in each study. Using a reflective and iterative process, we 
undertook thematic analysis to distill, structure and make 
sense of intervention development activity by coding 
and organising data into themes and subthemes. Each 
theme and subtheme provided a coherent description 
of the development work undertaken for each study, 
which were then synthesised into short descriptors to 
allow us to produce summary tables. The summary tables 
comprised a row for each study with columns for each 
theme and, where relevant, each subtheme. A second 
researcher checked, discussed and refined descriptors 
to ensure accuracy. From these descriptions, we then 
developed descriptive ratings on the quality of the inter-
vention development. Depending on the nature of the 
data, ratings were categorised and the iterative process 
involved two researchers refining and checking ratings 
to ensure they reflected the summary data from each 
study. In order to provide a visual representation of the 
quality of intervention development work, these ratings 
were then converted to a quality coding to indicate high 
quality, some or unclear quality or limited quality. For 
example, under co-design the highest quality rating was 
given when the intervention was co-designed with both 
clinical and service user input, a middle rating when either 
clinicians or service users were involved, and the lowest 
quality rating when neither clinicians nor service users 
were involved.
To examine the relationship between intervention 
development and treatment success, we applied mixed 
methods analytical techniques in novel ways. For each 
study, we combined ratings derived from the qualitative 
data on intervention development with the quantitative 
data on treatment outcomes in a joint display.
reSultS
We included 15 RCTs (figure 1),17–31 of which 13 used a 
two-arm, parallel RCT design, one was a two-arm cluster 
RCT and one was a four-arm factorial design (of which 
only two arms related to physical rehabilitation). Table 1 
provides a summary of the population, intervention, 
control and outcomes for each study. The combined 
sample size required to demonstrate a true difference in 
primary outcomes (excluding any inflation to account for 
loss to follow-up) was 7548 participants. The total number 
of participants who provided primary outcome data was 
higher than this (n=7834), likely due to lower loss to 
follow-up that estimated, although three studies19 29 30 
were considerably below their target sample size at the 
primary time point. Five primary outcomes were symp-
tom-based or clinical outcomes, seven were functional 
measures, two were combined measures and one assessed 
quality of life. Primary time points varied from immedi-
ately postintervention to 1 year (median 6 months). The 
health categories were stroke (n=4), neurological condi-
tions (n=2), inflammatory/immune system disorders 
(n=2), respiratory (n=1), musculoskeletal (n=1), cardio-
vascular (n=1), mental health (n=1), accident/injuries 
(n=1), renal/urogenital (n=1) and other (n=1). Seven 
interventions were delivered by physiotherapists, one 
by occupational therapists, one by speech and language 
therapists, one by nurses, two could be delivered by either 
a physiotherapist or a nurse, two could be delivered by a 
physiotherapist or an occupational therapist and one was 
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Figure 2 Classification of primary outcome.
Figure 3 Treatment success of included trials based on 
95% CI and minimum clinically important difference from 
sample size calculation (d).
delivered by both a physiotherapist and an occupational 
therapist. The chief investigators leading the studies were 
physicians (n=7), physiotherapists (n=5), occupational 
therapists (n=1), psychologists (n=1) and methodologists 
(n=1). The total amount of research funding awarded was 
£12 515 823.
One-third of studies (5/15) reported a definitive 
finding in favour of one of the treatment arms—four 
studies in favour of the new treatment, one in favour of 
the control. Of those with negative results, eight studies 
reported a true negative (no difference) outcome, one 
was inconclusive in favour of the new treatment and one 
inconclusive in favour of the control treatment (figures 2 
and 3).
Qualitative data informed 2 themes and 10 subthemes 
which enabled us to develop data-driven quality ratings:
1. Preparatory work (need for the study, underpinning the-
ory for the intervention, co-design, context consider-
ations and intervention piloting).
2. Intervention and control (intervention content and dose, 
individual tailoring, adherence strategies, standardised 
training, control content and dose).
Table 2 provides examples of summary data underpin-
ning each rating, with table 3 describing the quality rating 
for each study in chronological order. Table 4 presents 
the integrative qualitative and quantitative analysis using 
a joint display. No single study was deemed to be high 
quality in each subtheme. This said, the two best rated 
studies reported only expert clinical input into co-de-
signing the intervention with a lack of clear patient and 
public involvement; however, they reported a definitive 
trial outcome in favour of the new intervention. There 
does not appear to be a single aspect of intervention 
development driving study outcomes. This said, those 
with lower quality development work appear more likely 
to show no difference in outcomes compared with those 
with higher quality development work. Some areas of 
intervention development appear to be improving with 
time, these being articulating a clear need and theoret-
ical underpinning, co-design, piloting and descriptions of 
intervention and control components.
DiSCuSSiOn
Physical rehabilitation research targets a broad popu-
lation, although we found that studies for people with 
stroke to be the most common (n=4). We established that 
only one-third (5/15) of the RCTs of physical rehabilita-
tion funded by the NIHR HTA programme successfully 
demonstrated a statistically significant effect for one of 
the randomised groups in each trial. Four (27%) trials 
found an effect in favour of the ‘new’ intervention. 
Although we would not expect all studies to demon-
strate effectiveness in favour of the ‘new’ intervention, 
the equipoise principle implies that there would be no 
difference between the proportion of studies favouring 
intervention or control.9 However, this does not account 
for a null outcome. We were able to use contemporary 
research methods to develop an assessment of the quality 
of development work and assessed the included trials to 
be of varied quality in terms of intervention development 
work. In general, we found that comprehensive inter-
vention development may have a positive relationship 
with treatment success. Two studies23 31 with high quality 
intervention development reported treatment success, 
although two older25 28 and possibly less well reported 
trials also reported effective interventions. Develop-
ments in complex intervention evaluation,5 reporting 
standards16 32 and involving patients and the public in 
research33 have occurred since the inception of the HTA 
programme, and as such, some development work may 
have been undertaken but not reported in the older 
studies. A recent overview of approaches to developing 
interventions noted the absence of patient and public 
involvement.34 In addition, there was limited evidence 
of piloting the intervention prior to proceeding to the 
full trial with only four studies reporting this having 
copyright.
 o
n
 Septem
ber 16, 2019 at University of Exeter. Protected by
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-026289 on 28 August 2019. Downloaded from 
7Goodwin VA, et al. BMJ Open 2019;9:e026289. doi:10.1136/bmjopen-2018-026289
Open access
Ta
b
le
 2
 
D
es
cr
ip
tio
n 
of
 t
he
m
es
, s
ub
th
em
es
 a
nd
 q
ua
lit
y 
ra
tin
gs
 w
ith
 e
xa
m
p
le
s
T
he
m
e
S
ub
th
em
e
D
es
cr
ip
ti
o
n 
o
f 
ra
ti
ng
E
xa
m
p
le
s 
o
f 
d
at
a 
su
p
p
o
rt
in
g
 r
at
in
g
R
at
in
g
P
re
p
ar
at
or
y 
w
or
k
N
ee
d
 f
o
r 
th
e 
st
ud
y
M
ul
tip
le
 s
ou
rc
es
 o
f e
vi
d
en
ce
 o
f n
ee
d
 fo
r 
th
e 
st
ud
y,
 fo
r 
ex
am
p
le
, r
ec
en
t 
sy
st
em
at
ic
 r
ev
ie
w
, g
ui
d
el
in
es
, h
ig
h 
le
ve
l 
re
p
or
ts
, c
om
m
is
si
on
ed
 r
es
ea
rc
h,
 n
at
io
na
l a
ud
it
In
te
rn
at
io
na
l t
as
k 
fo
rc
e 
hi
gh
lig
ht
ed
 la
ck
 o
f e
vi
d
en
ce
 
an
d
 n
ee
d
 fo
r 
ev
al
ua
tio
n.
 C
oc
hr
an
e 
re
vi
ew
 d
re
w
 s
im
ila
r 
co
nc
lu
si
on
s.
 
 
S
in
gl
e 
so
ur
ce
 o
f e
vi
d
en
ce
/n
on
-s
ys
te
m
at
ic
 r
ev
ie
w
 t
o 
su
p
p
or
t 
ne
ed
 fo
r 
st
ud
y
O
ld
 s
ys
te
m
at
ic
 r
ev
ie
w
 in
d
ic
at
es
 p
au
ci
ty
 o
f h
ig
h 
q
ua
lit
y 
re
se
ar
ch
.
 
 
La
ck
 o
f c
la
rit
y 
or
 u
nd
er
p
in
ni
ng
 e
vi
d
en
ce
 r
eg
ar
d
in
g 
ne
ed
 
fo
r 
st
ud
y
P
oo
r 
ju
st
ifi
ca
tio
n 
fo
r 
th
e 
st
ud
y.
 E
vi
d
en
ce
 c
ite
d
 d
oe
s 
no
t 
su
p
p
or
t 
th
e 
ne
ed
 fo
r 
th
is
 p
ar
tic
ul
ar
 s
tu
d
y.
 
 
T
he
o
r e
ti
ca
l 
un
d
er
p
in
ni
ng
Th
eo
re
tic
al
 u
nd
er
p
in
ni
ng
 d
es
cr
ib
ed
P
hy
si
ol
og
ic
al
 a
nd
 p
sy
ch
ol
og
ic
al
 t
he
or
ie
s 
un
d
er
p
in
ni
ng
 
th
e 
in
te
rv
en
tio
n 
d
es
cr
ib
ed
 in
 d
et
ai
l.
 
 
La
ck
s 
cl
ea
r 
th
eo
re
tic
al
 u
nd
er
p
in
ni
ng
N
o 
in
fo
rm
at
io
n 
p
ro
vi
d
ed
 r
eg
ar
d
in
g 
th
e 
th
eo
re
tic
al
 b
as
is
 
fo
r 
th
e 
in
te
rv
en
tio
n 
p
ro
vi
d
ed
.
 
 
C
o
-d
es
ig
n
G
oo
d
 P
P
I a
nd
 e
xp
er
t 
cl
in
ic
al
 in
p
ut
P
at
ie
nt
s 
an
d
 c
lin
ic
ia
ns
 h
el
p
ed
 d
ev
el
op
 t
he
 in
te
rv
en
tio
n.
 
 
G
oo
d
 P
P
I b
ut
 w
ea
k 
or
 n
o 
ex
p
er
t 
cl
in
ic
al
 in
p
ut
/G
oo
d
 
cl
in
ic
al
 in
p
ut
 b
ut
 u
nc
le
ar
 o
r 
no
 P
P
I
C
lin
ic
ia
ns
 c
on
tr
ib
ut
ed
 t
o 
th
e 
in
te
rv
en
tio
n 
d
ev
el
op
m
en
t 
b
ut
 n
o 
in
d
ic
at
io
n 
of
 s
er
vi
ce
 u
se
r 
in
vo
lv
em
en
t.
 
 
N
o 
co
-d
es
ig
n
N
o 
co
-d
es
ig
n 
w
as
 u
nd
er
ta
ke
n 
to
 d
ev
el
op
 t
he
 
in
te
rv
en
tio
n.
 
 
C
o
nt
ex
tu
al
 
co
ns
id
er
at
io
ns
C
on
te
xt
 c
on
si
d
er
ed
Th
e 
us
e 
of
 d
iff
er
en
t 
p
ro
fe
ss
io
na
ls
 in
 d
el
iv
er
in
g 
th
e 
in
te
rv
en
tio
n 
re
fle
ct
ed
 t
he
 r
ea
l-
w
or
ld
 s
itu
at
io
n 
of
 h
ow
 t
hi
s 
w
ou
ld
 o
cc
ur
 in
 p
ra
ct
ic
e.
 
 
C
on
te
xt
 n
ot
 a
d
eq
ua
te
ly
 c
on
si
d
er
ed
Th
er
e 
w
as
 a
 la
ck
 o
f u
nd
er
st
an
d
in
g 
of
 r
el
ev
an
t 
co
nt
ex
t 
an
d
 fa
ct
or
s 
ne
ed
ed
 fo
r 
in
te
rv
en
tio
n 
d
ev
el
op
m
en
t 
an
d
 
d
el
iv
er
y.
 
 
P
ilo
ti
ng
 o
f 
in
te
rv
en
ti
o
n
P
ilo
t 
co
nd
uc
te
d
, e
va
lu
at
ed
 a
nd
 fi
nd
in
gs
 a
d
d
re
ss
ed
 fo
r 
m
ai
n 
ev
al
ua
tio
n
Th
e 
p
ilo
t 
d
at
a 
he
lp
ed
 r
efi
ne
 t
he
 in
te
rv
en
tio
n 
fo
r 
ev
al
ua
tio
n 
in
 t
he
 m
ai
n 
tr
ia
l.
 
 
P
ilo
t 
co
nd
uc
te
d
 b
ut
 fi
nd
in
gs
 n
ot
 c
le
ar
ly
 a
d
d
re
ss
ed
 in
 
in
te
rv
en
tio
n 
fo
r 
m
ai
n 
ev
al
ua
tio
n
Th
e 
p
ilo
t 
w
or
k 
le
d
 t
o 
a 
m
od
ifi
ca
tio
n 
of
 t
he
 c
on
tr
ol
 
in
te
rv
en
tio
n 
b
ut
 u
nc
le
ar
 a
s 
to
 w
he
th
er
 t
hi
s 
al
so
 
ha
p
p
en
ed
 fo
r 
th
e 
no
ve
l i
nt
er
ve
nt
io
n.
 
 
N
o 
p
ilo
t 
r e
p
or
te
d
N
o 
p
ilo
tin
g 
of
 in
te
rv
en
tio
n 
re
p
or
te
d
 
 
C
on
tin
ue
d
copyright.
 o
n
 Septem
ber 16, 2019 at University of Exeter. Protected by
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-026289 on 28 August 2019. Downloaded from 
8 Goodwin VA, et al. BMJ Open 2019;9:e026289. doi:10.1136/bmjopen-2018-026289
Open access 
T
he
m
e
S
ub
th
em
e
D
es
cr
ip
ti
o
n 
o
f 
ra
ti
ng
E
xa
m
p
le
s 
o
f 
d
at
a 
su
p
p
o
rt
in
g
 r
at
in
g
R
at
in
g
In
te
rv
en
tio
n 
an
d
 c
on
tr
ol
C
o
nt
en
t 
an
d
 
d
o
se
In
te
rv
en
tio
n 
co
m
p
on
en
ts
 a
nd
 d
os
e 
cl
ea
rly
 d
es
cr
ib
ed
Th
e 
co
nt
en
t 
an
d
 t
he
 d
os
e 
of
 t
he
 e
xe
rc
is
e 
p
ro
gr
am
m
e 
w
er
e 
d
es
cr
ib
ed
 in
 d
et
ai
l.
 
 
In
te
rv
en
tio
n 
co
m
p
on
en
ts
 c
le
ar
ly
 d
es
cr
ib
ed
 b
ut
 d
os
e 
w
as
 
no
t 
st
an
d
ar
d
is
ed
Th
e 
co
nt
en
t 
of
 t
he
 p
ro
gr
am
m
e 
w
as
 w
el
l d
es
cr
ib
ed
 b
ut
 
no
 s
p
ec
ifi
c 
d
os
e 
w
as
 p
re
sc
rib
ed
.
 
 
In
te
rv
en
tio
n 
no
t 
re
p
lic
ab
le
 fr
om
 d
es
cr
ip
tio
n 
of
 
co
m
p
on
en
ts
 a
nd
 d
os
e
In
te
rv
en
tio
n 
w
as
 b
as
ed
 o
n 
us
ua
l p
ra
ct
ic
e 
an
d
 h
ad
 n
o 
p
ro
to
co
l o
r 
gu
id
an
ce
 o
n 
m
in
im
um
 d
os
e.
 
 
Ta
ilo
ri
ng
Fo
rm
al
is
ed
 a
ss
es
sm
en
t 
to
 in
fo
rm
 t
ai
lo
rin
g
A
n 
as
se
ss
m
en
t 
to
ol
 w
as
 u
se
d
 t
o 
d
et
er
m
in
e 
th
e 
in
d
iv
id
ua
ls
 le
ve
l o
f e
xe
rc
is
e 
in
te
ns
ity
 
 
C
lin
ic
al
 ju
d
ge
m
en
t 
on
ly
 u
se
d
 t
o 
in
fo
rm
 t
ai
lo
rin
g
Th
er
ap
is
ts
 u
se
d
 t
he
ir 
cl
in
ic
al
 ju
d
ge
m
en
t 
to
 in
d
iv
id
ua
lly
 
ta
ilo
r 
p
ro
gr
am
m
es
.
 
 
N
ot
 a
d
eq
ua
te
ly
 r
ep
or
te
d
In
te
rv
en
tio
n 
in
d
iv
id
ua
lly
 t
ai
lo
re
d
 b
ut
 n
o 
in
fo
rm
at
io
n 
as
 t
o 
ho
w
 t
hi
s 
w
as
 u
nd
er
ta
ke
n.
 
 
A
d
he
re
nc
e 
su
p
p
o
rt
 
st
ra
te
g
ie
s
E
xp
lic
it 
st
ra
te
gi
es
 t
o 
su
p
p
or
t 
ad
he
re
nc
e 
to
 t
he
 
in
te
rv
en
tio
n 
cl
ea
rly
 r
ep
or
te
d
S
p
ec
ifi
c 
ad
he
re
nc
e 
st
ra
te
gi
es
 d
es
cr
ib
ed
 a
s 
p
ar
t 
of
 t
he
 
in
te
rv
en
tio
n.
 
 
N
o 
cl
ea
r 
in
fo
rm
at
io
n 
re
ga
rd
in
g 
ad
he
re
nc
e 
su
p
p
or
t 
st
ra
te
gi
es
N
o 
in
fo
rm
at
io
n 
re
p
or
te
d
 r
eg
ar
d
in
g 
ad
he
re
nc
e 
st
ra
te
gi
es
.
 
 
S
up
p
or
tin
g 
ad
he
re
nc
e 
is
 n
ot
 r
el
ev
an
t 
to
 t
he
 in
te
rv
en
tio
n
Th
e 
in
te
rv
en
tio
n 
w
as
 p
as
si
ve
 a
nd
 a
d
he
re
nc
e 
st
ra
te
gi
es
 
no
t 
re
le
va
nt
.
N
A
In
te
rv
en
ti
o
n 
tr
ai
ni
ng
S
ta
nd
ar
d
is
ed
 t
ra
in
in
g 
in
 in
te
rv
en
tio
n 
re
ce
iv
ed
 +
/-
 
ad
d
iti
on
al
/o
ng
oi
ng
 s
up
p
or
t 
or
 t
ra
in
in
g
S
ta
ff 
at
te
nd
ed
 a
 1
.5
-d
ay
 t
ra
in
in
g 
se
ss
io
n 
an
d
 h
ad
 a
n 
ad
d
iti
on
al
 s
up
p
or
t 
se
ss
io
n 
w
ith
 o
ng
oi
ng
 c
on
ta
ct
 fr
om
 
re
se
ar
ch
 t
ea
m
.
 
 
N
o 
st
an
d
ar
d
is
ed
 in
te
rv
en
tio
n 
tr
ai
ni
ng
 r
ec
ei
ve
d
 b
ut
 s
ta
ff 
d
el
iv
er
in
g 
d
es
cr
ib
ed
 t
o 
b
e 
ex
p
er
ie
nc
ed
 in
 t
he
 in
te
rv
en
tio
n 
or
 t
ra
in
in
g 
of
 s
ta
ff 
un
cl
ea
r/
no
t 
re
p
or
te
d
S
ta
ff 
ha
ve
 p
os
tg
ra
d
ua
te
 t
ra
in
in
g 
in
 t
he
 in
te
rv
en
tio
n 
b
ut
 
no
 s
tu
d
y-
sp
ec
ifi
c 
tr
ai
ni
ng
 r
ep
or
te
d
.
 
 
C
o
nt
ro
l 
d
es
cr
ip
ti
o
n
A
ct
iv
e 
co
nt
ro
l/a
tt
en
tio
n 
co
nt
ro
l/u
su
al
 c
ar
e 
w
ith
 s
om
e 
st
an
d
ar
d
is
ed
 c
om
p
on
en
ts
C
on
tr
ol
 w
as
 a
n 
ac
tiv
e 
in
te
rv
en
tio
n 
th
at
 d
iff
er
ed
 fr
om
 
in
te
rv
en
tio
n 
on
ly
 in
 t
er
m
s 
of
 d
el
iv
er
y 
se
tt
in
g.
 
 
U
su
al
 c
ar
e 
ha
d
 n
o 
st
an
d
ar
d
is
ed
 c
om
p
on
en
ts
C
on
tr
ol
 w
as
 u
su
al
 c
ar
e 
an
d
 w
as
 n
ot
 s
ta
nd
ar
d
is
ed
 
b
et
w
ee
n 
si
te
s.
 
 
K
ey
: 
  H
ig
h 
q
ua
lit
y 
  S
om
e/
U
nc
le
ar
 q
ua
lit
y 
  L
im
ite
d
 q
ua
lit
y.
P
P
I, 
P
at
ie
nt
 a
nd
 P
ub
lic
 In
vo
lv
em
en
t.
Ta
b
le
 2
 
C
on
tin
ue
d
copyright.
 o
n
 Septem
ber 16, 2019 at University of Exeter. Protected by
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-026289 on 28 August 2019. Downloaded from 
9Goodwin VA, et al. BMJ Open 2019;9:e026289. doi:10.1136/bmjopen-2018-026289
Open access
Ta
b
le
 3
 
Q
ua
lit
y 
of
 in
te
rv
en
tio
n 
d
ev
el
op
m
en
t 
w
or
k 
or
d
er
ed
 b
y 
ye
ar
 o
f p
ub
lic
at
io
n
A
ut
ho
r 
(y
ea
r)
N
ee
d
T
he
o
ry
C
o
-d
es
ig
n
C
o
nt
ex
t
P
ilo
t
In
te
rv
en
ti
o
n 
co
nt
en
t
Ta
ilo
re
d
A
d
he
re
nc
e 
st
ra
te
g
ie
s
Tr
ai
ni
ng
 d
el
iv
er
y
C
o
nt
ro
l d
es
cr
ip
ti
o
n
M
cC
ar
th
y 
(2
00
4)
25
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
V
ic
ke
rs
 (2
00
4)
28
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N
A
 
 
 
 
E
p
p
s 
(2
00
5)
19
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
W
ei
nd
lin
g 
(2
00
7)
30
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Jo
lly
 (2
00
7)
22
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
W
at
er
ho
us
e 
(2
01
0)
29
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
G
la
ze
ne
r 
(2
01
1)
20
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B
ow
en
 (2
01
2)
17
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
La
m
b
 (2
01
2)
23
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U
nd
er
w
oo
d
 (2
01
3)
27
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lo
ga
n 
(2
01
4)
24
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A
V
E
R
T 
G
ro
up
 (2
01
5)
21
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N
A
 
 
 
 
W
ill
ia
m
s 
(2
01
5)
31
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S
ac
kl
ey
 (2
01
6)
26
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C
la
rk
e 
(2
01
6)
18
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
K
ey
: 
  H
ig
h 
q
ua
lit
y 
  S
om
e/
U
nc
le
ar
 q
ua
lit
y 
  L
im
ite
d
 q
ua
lit
y.
N
A
, N
ot
 A
p
p
lic
ab
le
.
copyright.
 o
n
 Septem
ber 16, 2019 at University of Exeter. Protected by
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-026289 on 28 August 2019. Downloaded from 
10 Goodwin VA, et al. BMJ Open 2019;9:e026289. doi:10.1136/bmjopen-2018-026289
Open access 
Ta
b
le
 4
 
Jo
in
t 
d
is
p
la
y 
of
 t
re
at
m
en
t 
su
cc
es
s 
or
d
er
ed
 b
y 
q
ua
lit
y 
of
 in
te
rv
en
tio
n 
d
ev
el
op
m
en
t 
w
or
k
A
ut
ho
r
N
ee
d
T
he
o
ry
C
o
-d
es
ig
n
C
o
nt
ex
t
P
ilo
t
In
te
rv
en
ti
o
n 
co
nt
en
t
Ta
ilo
re
d
A
d
he
re
nc
e 
st
ra
te
g
ie
s
Tr
ai
ni
ng
 
d
el
iv
er
y
C
o
nt
ro
l 
d
es
cr
ip
ti
o
n
Tr
ea
tm
en
t 
su
cc
es
s
La
m
b
23
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S
ta
tis
tic
al
ly
 
si
gn
ifi
ca
nt
 in
 fa
vo
ur
 
of
 in
te
rv
en
tio
n
W
ill
ia
m
s3
1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S
ta
tis
tic
al
ly
 
si
gn
ifi
ca
nt
 in
 fa
vo
ur
 
of
 in
te
rv
en
tio
n
U
nd
er
w
oo
d
41
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tr
ue
 n
eg
at
iv
e 
(N
o 
d
iff
er
en
ce
)
G
la
ze
ne
r2
0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tr
ue
 n
eg
at
iv
e 
(N
o 
d
iff
er
en
ce
)
Lo
ga
n2
4
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tr
ue
 n
eg
at
iv
e 
(N
o 
d
iff
er
en
ce
)
B
ow
en
17
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In
co
nc
lu
si
ve
 in
 
fa
vo
ur
 o
f i
nt
er
ve
nt
io
n
A
V
E
R
T 
G
ro
up
21
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N
A
 
 
 
 
S
ta
tis
tic
al
ly
 
si
gn
ifi
ca
nt
 in
 fa
vo
ur
 
of
 c
on
tr
ol
S
ac
kl
ey
26
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tr
ue
 n
eg
at
iv
e 
(N
o 
d
iff
er
en
ce
)
Jo
lly
22
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tr
ue
 n
eg
at
iv
e 
(N
o 
d
iff
er
en
ce
)
M
cC
ar
th
y2
5
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S
ta
tis
tic
al
ly
 
si
gn
ifi
ca
nt
 in
 fa
vo
ur
 
of
 in
te
rv
en
tio
n
W
at
er
ho
us
e2
9
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tr
ue
 n
eg
at
iv
e 
(N
o 
d
iff
er
en
ce
)
E
p
p
s1
9
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In
co
nc
lu
si
ve
 in
 
fa
vo
ur
 o
f c
on
tr
ol
C
la
rk
e1
8
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tr
ue
 n
eg
at
iv
e 
(N
o 
d
iff
er
en
ce
)
V
ic
ke
rs
28
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N
A
 
 
 
 
S
ta
tis
tic
al
ly
 
si
gn
ifi
ca
nt
 in
 fa
vo
ur
 
of
 in
te
rv
en
tio
n
W
ei
nd
lin
g3
0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tr
ue
 n
eg
at
iv
e 
(N
o 
d
iff
er
en
ce
)
K
ey
: 
  H
ig
h 
q
ua
lit
y 
  S
om
e/
U
nc
le
ar
 q
ua
lit
y 
  L
im
ite
d
 q
ua
lit
y
N
A
, n
ot
 a
p
p
lic
ab
le
.
copyright.
 o
n
 Septem
ber 16, 2019 at University of Exeter. Protected by
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-026289 on 28 August 2019. Downloaded from 
11Goodwin VA, et al. BMJ Open 2019;9:e026289. doi:10.1136/bmjopen-2018-026289
Open access
been done. Most (>80%) drug intervention development 
studies fail to reach the ‘phase III’ trial stage.35 Public 
health interventions have tended to go straight to an RCT 
without piloting, which may contribute to challenges 
in demonstrating effectiveness.11 There are, of course, 
other factors that influence trial findings, including trial 
methods and conduct; however, our question was specif-
ically determined to explore what, if any, relationship 
existed between intervention development and outcomes 
and not in the effectiveness of particular interventions.
A strength of our study is the use of integrative mixed 
methods analysis which has enabled us to explore the rela-
tionship between development work and outcome. This 
rarely used approach in evidence synthesis36 has given us 
a unique insight that would not have been possible using 
a quantitative or qualitative analysis alone. A limitation 
of our work could be the focus on a single UK funding 
stream which does not necessarily reflect the body of 
research funded from other sources, and therefore, the 
quality of intervention development work is not neces-
sarily generalisable. However, the NIHR HTA programme 
is the single largest funder of RCTs of applied health 
research in the UK. They publish detailed monographs 
of their funded studies, along with protocols and other 
supporting publications that provide a detailed and rich 
source of data beyond what would normally be available 
in journal-based peer-reviewed publications alone. We 
were able to retain the essence and nuances of the quali-
tative data while developing categorical ratings of quality 
to help us better explore the relationship between devel-
opment work and treatment success.
Our findings are similar to those of Dent and Raftery9 
in relation to those trials showing a benefit who reported 
19% (16/85) of studies found in favour of the new inter-
vention. It has been suggested that a 50% success rate is 
a good investment for healthcare research37; however, 
our findings indicate that the studies we reviewed fell 
well below this. In contrast, we observed a considerably 
larger proportion of true negative studies (8/15; 53%) 
compared with 19/85 (22%) reported by Dent and 
Raftery.9 The difference is even greater when compared 
with a review of cancer trials in the USA where only 2% 
of trials found a true negative outcome.10 The reasons for 
the differences are unclear but could include the prag-
matic nature of HTA-funded trials and the relative smaller 
effect sizes often associated with trials of rehabilitation.38
It has been recently suggested that RCTs should only 
be undertaken if they are justified both scientifically and 
ethically by having a clear hypothesis and established 
uncertainty39 and our findings support that by way of 
good quality intervention development work. Our find-
ings also align with the elements suggested to be key for 
developing interventions and reducing research waste by 
increasing the likelihood of success40 which will form a 
comprehensive supplement to the development phase 
of the updated MRC guidance on developing and eval-
uating interventions due for publication in 2019. The 
NIHR HTA is publicly funded and by increasing effort 
and focus on developing rehabilitation and other inter-
ventions in the future, researchers and funding bodies 
could increase the possibility of a definitive trial reporting 
beneficial findings after much investment of time and 
public money.
COnCluSiOnS
Despite much research effort and funding, only 4 out 
of 15 evaluations of ‘new’ rehabilitation interventions 
funded by the NIHR HTA programme were found to be 
unequivocally effective. Most studies reported no differ-
ence in outcome between study arms. We have used 
mixed methods research to explore the relationship 
between intervention development work and treatment 
success and developed a method of assessing the quality 
of this work, which suggests comprehensive intervention 
development work may have a positive relationship with 
treatment success.
recommendations
As this was an exploratory study, further work should be 
undertaken to establish the validity of quality assessment 
of intervention development work. This said, researchers 
and funding agencies should not undervalue the poten-
tial benefit of high quality intervention development 
work prior to definitive RCTs to reduce the likelihood of 
a null outcome and improve current rates of treatment 
success.
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